focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Tempted this morning to take some profit but glad I didn’t safe place for my investment to grow I believe.
A contributor to ADVFN listened into the conference call & remarked that our CEO sounded very confident in respect of both our Advair generic & case V GSK
Vectura has tripled its customers Base
Vectura is helping there various customers combat the corona virus
Just keep Buying in my view
We will get to £2 as a long term Target
Quick glance through the results suggests all is going to plan, revenue's slightly down but cash equivalents up, and no right downs so posting a profit, several new contracts signed.
No major breakthrough news with approval of generic Advair® programme (VR315 (US)), partnered with Hikma, in H2 2020 still in waiting, and the GSK issue still to be fully resolved, both of these issues will be positive if they go VECs way.
All in all its looks positive going forwards.
Seat Belts on
Great Results
Share price will Break the 120 pence and test 150pence
I suspect that todays RNS is more significant than it looks & perhaps it will be elaborated on in tomorrows results.
This will double from here
Great article straight to the point use the inhalers and save lives.
‘The World Health Organization (WHO) recommends that oxytocin is administered to every woman after birth to prevent PPH, and currently, the only option for administration is via injection.’ - A reasonably sized market then?
Agree
Repression same for me understanding some basics of this kind of RNS but any involvement from Black Rock you have to take notice one if not the best investment CO in the world.
Funny just noticed that myself. Never quite understand these TR-1's but I assume Blackrock have been buying and have/or about to cross a threshold where they have to notify. Have they bought because they think the stock is good or have they bought because they are just tracking an index and Vec needs to be included?
Just noticed a late RNS put out Friday night anyone like to comment.
Good news regarding GSK & our collaboration with HIK would be very welcome, although unlikely now as only 1 trading day remains before Results.It will be interesting to see the extent to which our new direction & strategy has been performing along with our new senior management team.If we are lucky we may even , one day, each the heady heights of our SP when I was acquired from SKP -where I was very happy .
Not long to wait now, inclusion into FTSE 250, sp steady the market is giving us the impression that all is as should be.
Hopefully management can drop us some good unexpected news regarding GSK, confirm cash generation has continued resulting in an increase in cash, plus all areas of the business are looking promising, perhaps news of more collaboration ventures with others HIK, opportunities galore which VEC are being asked to partner with others, well we can hope.
Novartis post hoc analysis from Phase III trial shows high-dose Enerzair® Breezhaler® reduces asthma exacerbations versus medium-dose, complementing key pivotal IRIDIUM study findings.
Excellent news for VEC - will VEC issue an RNS later?
hTtps://www.investegate.co.uk/novartis-ag-chf0-50-regd-/gnw/novartis-post-hoc-analysis-shows-high-dose-enerzair--174--breezhaler--174--reduces-asthma-exacerbations-versus-medium-dose--complementing-key-pivotal-iridium-study-findings/20200907061500H5850/
Vectura will Volcano up to 150pence
with 200pence swiftly to follow
Sit Tight enjoy the Ride up
On 15/9 will set her tone for the direction of our SP & the outlook statement will be pivotal in respect of the evolution of our new strategy .Our CEO doesn’t have a crystal ball so will be unable to confirm outcomes for Advair & GSK case -but hopefully all else will be positive & we are continuing generating cash & developing new opportunities .Remaining optimistic !
Yes, it finally made it into the 250.
Hopefully inclusion will be announced tomorrow which should result in steady buying from trackers & funds.Lets hope ourcresults justify our increased SP & that the momentum will be maintained,assisted by positive news regarding our Advair Generic
Once we Break 120pence
We can Volcano to 150pence very quickly
The market has not realised the covid potential for Vectura
I think the breakthrough will come via the inhalers together with a combination of Remdesivir
Vectura is Overwhelmed with Demand
I am sure all the news will come to light soon
For example Verona pharma is using inhalers with a combination of Remdesivir announcement was on friday
Any predictions for this week? 1.25 by Friday is mine.
Gilead to begin clinical trials of inhaled version of Remdesivir on covid 19 patient
/>https://youtu.be/PrEsJrg1QHg
great article
https://www.uspharmacist.com/article/oral-inhaled-remdesivir-for-covid19-may-become-available-at-some-point